This is a brand page for the RING trademark by RING THERAPEUTICS, INC.
in *********, **********, ***** ****.
Write a review about a product or service associated with this RING trademark.
Or, contact the owner RING THERAPEUTICS, INC. of the RING trademark by filing a request to communicate with
the Legal Correspondent for licensing, use, and/or questions related to the RING trademark.
On Thursday, January 2, 2020,
a U.S. federal trademark registration was filed for
RING.
The USPTO has given the RING
trademark serial number of 88744777.
The current federal status of this trademark filing is FOURTH EXTENSION - GRANTED.
The correspondent listed for RING is
CHRISTINA M. LICURSI, ESQ. of
********,********, ***** ****
.
The RING trademark is filed in the category of
Pharmaceutical Products
.
The description provided to the USPTO for RING
is encapsulated nucleic acids for use as biological therapeutics in gene therapy for the treatment of rare genetic disorders, cardiovascular diseases, respiratory diseases, infectious diseases, retinal diseases, metabolic disorders, hormonal deficiencies, endocrine diseases, eye diseases and disorders, intestinal diseases, autoimmune diseases, autoinflammatory diseases, inflammatory disorders, musculoskeletal diseases, neurological disorders, hematologic conditions, cutaneous conditions, neurodegenerative diseases, congenital disorders, kidney and urinary diseases, reproductive diseases, mitochondrial diseases, lung disorders, immune system diseases, mouth diseases, digestive diseases; pharmaceutical preparations for use in the prevention, diagnosis and treatment of disease, namely, rare genetic disorders, cardiovascular diseases, respiratory diseases, infectious diseases, retinal diseases, metabolic disorders, hormonal deficiencies, endocrine diseases, eye diseases and disorders, intestinal diseases, autoimmune diseases, autoinflammatory diseases, inflammatory disorders, musculoskeletal diseases, neurological disorders, hematologic conditions, cutaneous conditions, neurodegenerative diseases, congenital disorders, kidney and urinary diseases, reproductive diseases, mitochondrial diseases, lung disorders, immune system diseases, mouth diseases, digestive diseases; pharmaceutical preparations for use in gene therapy.